In the present review of the literature, we highlight multiple mechanisms implicating the EPH/ephrin signaling pathway in bone (osteosarcoma, chondrosarcoma, Ewing’s sarcoma) and soft tissue sarcomas (synovial sarcoma, rhabdomyosarcoma) based on published in vitro and in vivo studies. Here, EPHA1 is linked to soft tissue sarcoma.